Nicotine vaccines to treat tobacco dependence

References

• UN Office on Drugs and Crime. World drug report 2011. [http://www.humansecuritygateway.com/showRecord.php?RecordId=35492 (accessed on March 15, 2012)]
   Google Scholar
• Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379:55 - 70; http://dx.doi.org/10.1016/S0140-6736(11)61138-0; PMID: 22225671
   PubMed Web of Science ®Google Scholar
• Kessler R, Üstün T. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. Cambridge: Cambridge University Press, 2008.
   Google Scholar
• Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008; 5:e141; http://dx.doi.org/10.1371/journal.pmed.0050141; PMID: 18597549
   PubMed Web of Science ®Google Scholar
• Daniel JZ, Hickman M, Macleod J, Wiles N, Lingford-Hughes A, Farrell M, et al. Is socioeconomic status in early life associated with drug use? A systematic review of the evidence. Drug Alcohol Rev 2009; 28:142 - 53; http://dx.doi.org/10.1111/j.1465-3362.2008.00042.x; PMID: 19320699
   PubMed Web of Science ®Google Scholar
• Glantz MD, Anthony JC, Berglund PA, Degenhardt L, Dierker L, Kalaydjian A, et al. Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychol Med 2009; 39:1365 - 77; http://dx.doi.org/10.1017/S0033291708004510; PMID: 19046473
   PubMed Web of Science ®Google Scholar
• WHO. The ICD-10 classification of mental and behavioural disorders – diagnostic criteria for research. Geneva: World Health Organization, 1993.
   Google Scholar
• APA. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th edn. Washington, DC: American Psychiatric Association, 2000.
   Google Scholar
• Diana M. The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry 2011; 2:64; http://dx.doi.org/10.3389/fpsyt.2011.00064; PMID: 22144966
   PubMedGoogle Scholar
• Stotts AL, Dodrill CL, Kosten TR. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 2009; 10:1727 - 40; http://dx.doi.org/10.1517/14656560903037168; PMID: 19538000
   PubMed Web of Science ®Google Scholar
• Kahan M, Srivastava A, Ordean A, Cirone S. Buprenorphine: new treatment of opioid addiction in primary care. Can Fam Physician 2011; 57:281 - 9; PMID: 21402963
   PubMed Web of Science ®Google Scholar
• Vadivelu N, Hines RL. Buprenorphine: a unique opioid with broad clinical applications. J Opioid Manag 2007; 3:49 - 58; PMID: 17367094
   PubMedGoogle Scholar
• Kreek MJ, Borg L, Ducat E, Ray B. Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis 2010; 29:200 - 16; http://dx.doi.org/10.1080/10550881003684798; PMID: 20407977
   PubMed Web of Science ®Google Scholar
• Shen XY, Orson FM, Kosten TR. Vaccines against drug abuse. Clin Pharmacol Ther 2012; 91:60 - 70; http://dx.doi.org/10.1038/clpt.2011.281; PMID: 22130115
   PubMed Web of Science ®Google Scholar
• Moreno AY, Janda KD. Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence. Pharmacol Biochem Behav 2009; 92:199 - 205; http://dx.doi.org/10.1016/j.pbb.2009.01.015; PMID: 19350728
   PubMed Web of Science ®Google Scholar
• Carroll FI, Blough BE, Pidaparthi RR, Abraham P, Gong PK, Deng L, et al. Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines. J Med Chem 2011; 54:5221 - 8; http://dx.doi.org/10.1021/jm2004943; PMID: 21682289
   PubMed Web of Science ®Google Scholar
• Moreno AY, Mayorov AV, Janda KD. Impact of distinct chemical structures for the development of a methamphetamine vaccine. J Am Chem Soc 2011; 133:6587 - 95; http://dx.doi.org/10.1021/ja108807j; PMID: 21473576
   PubMed Web of Science ®Google Scholar
• Li QQ, Luo YX, Sun CY, Xue YX, Zhu WL, Shi HS, et al. A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats. J Neurochem 2011; 119:1271 - 81; http://dx.doi.org/10.1111/j.1471-4159.2011.07502.x; PMID: 21951213
   PubMed Web of Science ®Google Scholar
• Haney M, Kosten TR. Therapeutic vaccines for substance dependence. Expert Rev Vaccines 2004; 3:11 - 8; http://dx.doi.org/10.1586/14760584.3.1.11; PMID: 14761239
   PubMedGoogle Scholar
• Esson L, Leeder SR. The millennium development goals and tobacco control: an opportunity for global partnership. Geneva: World Health Organization (WHO): 2004.
   Google Scholar
• Tobacco Free Initiative (TFI). Why is tobacco a public health priority? World Health Organization (WHO): 2005 [http://www.who.int/tobacco/health_priority/en (accessed on March 15, 2012)]
   Google Scholar
• Rose JE, Mukhin AG, Lokitz SJ, Turkington TG, Herskovic J, Behm FM, et al. Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine. Proc Natl Acad Sci U S A 2010; 107:5190 - 5; http://dx.doi.org/10.1073/pnas.0909184107; PMID: 20212132
   PubMed Web of Science ®Google Scholar
• Houtsmuller EJ, Henningfield JE, Stitzer ML. Subjective effects of the nicotine lozenge: assessment of abuse liability. Psychopharmacology (Berl) 2003; 167:20 - 7; PMID: 12616334
   PubMed Web of Science ®Google Scholar
• Benowitz NL. Nicotine addiction. N Engl J Med 2010; 362:2295 - 303; http://dx.doi.org/10.1056/NEJMra0809890; PMID: 20554984
   PubMed Web of Science ®Google Scholar
• Polosa R, Benowitz NL. Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci 2011; 32:281 - 9; http://dx.doi.org/10.1016/j.tips.2010.12.008; PMID: 21256603
   PubMed Web of Science ®Google Scholar
• Frishman WH. Smoking cessation pharmacotherapy. Ther Adv Cardiovasc Dis 2009; 3:287 - 308; http://dx.doi.org/10.1177/1753944709335754; PMID: 19491139
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. 2004 Surgeon General’s Report – The health consequences of smoking. [http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm (accessed on March 15, 2012)]
   Google Scholar
• Rose JE. Disrupting nicotine reinforcement: from cigarette to brain. Ann N Y Acad Sci 2008; 1141:233 - 56; http://dx.doi.org/10.1196/annals.1441.019; PMID: 18991961
   PubMed Web of Science ®Google Scholar
• Kosten T, Owens SM. Immunotherapy for the treatment of drug abuse. Pharmacol Ther 2005; 108:76 - 85; http://dx.doi.org/10.1016/j.pharmthera.2005.06.009; PMID: 16023218
   PubMed Web of Science ®Google Scholar
• Orson FM, Kinsey BM, Singh RAK, Wu Y, Gardner T, Kosten TR. Substance abuse vaccines. Ann N Y Acad Sci 2008; 1141:257 - 69; http://dx.doi.org/10.1196/annals.1441.027; PMID: 18991962
   PubMed Web of Science ®Google Scholar
• Escobar-Chávez JJ, Domínguez-Delgado CL, Rodríguez-Cruz IM. Targeting nicotine addiction: the possibility of a therapeutic vaccine. Drug Des Devel Ther 2011; 5:211 - 24; http://dx.doi.org/10.2147/DDDT.S10033; PMID: 21607018
   PubMed Web of Science ®Google Scholar
• Cerny EH, Cerny T. Vaccines against nicotine. Hum Vaccin 2009; 5:200 - 5; http://dx.doi.org/10.4161/hv.5.4.7310; PMID: 19276649
   PubMed Web of Science ®Google Scholar
• de Villiers SHL, Lindblom N, Kalayanov G, Gordon S, Baraznenok I, Malmerfelt A, et al. Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure. Vaccine 2010; 28:2161 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.12.051; PMID: 20060511
   PubMed Web of Science ®Google Scholar
• Keyler DE, Dufek MB, Calvin AD, Bramwell TJ, LeSage MG, Raphael DE, et al. Reduced nicotine distribution from mother to fetal brain in rats vaccinated against nicotine: time course and influence of nicotine dosing regimen. Biochem Pharmacol 2005; 69:1385 - 95; http://dx.doi.org/10.1016/j.bcp.2005.02.007; PMID: 15826609
   PubMed Web of Science ®Google Scholar
• LeSage MG, Keyler DE, Hieda Y, Collins G, Burroughs D, Le C, et al. Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats. Psychopharmacology (Berl) 2006; 184:409 - 16; http://dx.doi.org/10.1007/s00213-005-0027-2; PMID: 15991003
   PubMed Web of Science ®Google Scholar
• Sanderson SD, Cheruku SR, Padmanilayam MP, Vennerstrom JL, Thiele GM, Palmatier MI, et al. Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant. Int Immunopharmacol 2003; 3:137 - 46; http://dx.doi.org/10.1016/S1567-5769(02)00260-6; PMID: 12538044
   PubMed Web of Science ®Google Scholar
• Keyler DE, Hieda Y, St Peter J, Pentel PR. Altered disposition of repeated nicotine doses in rats immunized against nicotine. Nicotine Tob Res 1999; 1:241 - 9; http://dx.doi.org/10.1080/14622299050011361; PMID: 11072421
   PubMedGoogle Scholar
• Pravetoni M, Keyler DE, Pidaparthi RR, Carroll FI, Runyon SP, Murtaugh MP, et al. Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities. Biochem Pharmacol 2012; 83:543 - 50; http://dx.doi.org/10.1016/j.bcp.2011.11.004; PMID: 22100986
   PubMed Web of Science ®Google Scholar
• Selecta Biosciences: Recent news. Selecta Biosciences Initiates Phase 1 Clinical Study of SEL-068, a First-in-Class Synthetic Nicotine Vaccine for Smoking Cessation and Relapse Prevention [http://www.selectabio.com/news/recent-news/Selecta-Biosciences-Initiates-Phase-1-Clinical-Study-of-SEL-068.cfm (accessed on January 14, 2012)]
   Google Scholar
• Cornish KE, Harris AC, LeSage MG, Keyler DE, Burroughs D, Earley C, et al. Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy. Int Immunopharmacol 2011; 11:1809 - 15; http://dx.doi.org/10.1016/j.intimp.2011.07.009; PMID: 21802529
   PubMed Web of Science ®Google Scholar
• Malin DH, Moon WD, Goyarzu P, Magallanes N, Blair MB, Alexander MR, et al. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat. Nicotine Tob Res 2010; 12:438 - 44; http://dx.doi.org/10.1093/ntr/ntq021; PMID: 20203107
   PubMed Web of Science ®Google Scholar
• Raupach T, Hoogsteder PHJ, Onno van Schayck CP. Nicotine vaccines to assist with smoking cessation: current status of research. Drugs 2012; 72:e1 - 16; http://dx.doi.org/10.2165/11599900-000000000-00000; PMID: 22356293
   PubMedGoogle Scholar
• Hasman A, Holm S. Nicotine conjugate vaccine: is there a right to a smoking future?. J Med Ethics 2004; 30:344 - 5; http://dx.doi.org/10.1136/jme.2002.001602; PMID: 15289514
   PubMed Web of Science ®Google Scholar
• Kinsey BM, Jackson DC, Orson FM. Anti-drug vaccines to treat substance abuse. Immunol Cell Biol 2009; 87:309 - 14; http://dx.doi.org/10.1038/icb.2009.17; PMID: 19333250
   PubMed Web of Science ®Google Scholar
• Keyler DE, Roiko SA, Earley CA, Murtaugh MP, Pentel PR. Enhanced immunogenicity of a bivalent nicotine vaccine. Int Immunopharmacol 2008; 8:1589 - 94; http://dx.doi.org/10.1016/j.intimp.2008.07.001; PMID: 18656557
   PubMed Web of Science ®Google Scholar
• Hieda Y, Keyler DE, Ennifar S, Fattom A, Pentel PR. Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain. Int J Immunopharmacol 2000; 22:809 - 19; http://dx.doi.org/10.1016/S0192-0561(00)00042-4; PMID: 10963853
   PubMed Web of Science ®Google Scholar
• Satoskar SD, Keyler DE, LeSage MG, Raphael DE, Ross CA, Pentel PR. Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats. Int Immunopharmacol 2003; 3:957 - 70; http://dx.doi.org/10.1016/S1567-5769(03)00094-8; PMID: 12810353
   PubMed Web of Science ®Google Scholar
• Pravetoni M, Keyler DE, Raleigh MD, Harris AC, Lesage MG, Mattson CK, et al. Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochem Pharmacol 2011; 81:1164 - 70; http://dx.doi.org/10.1016/j.bcp.2011.02.004; PMID: 21333633
   PubMed Web of Science ®Google Scholar
• Hatsukami DK, Jorenby DE, Gonzales D, Rigotti NA, Glover ED, Oncken CA, et al. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther 2011; 89:392 - 9; http://dx.doi.org/10.1038/clpt.2010.317; PMID: 21270788
   PubMed Web of Science ®Google Scholar
• Wagena EJ, de Vos A, Horwith G, van Schayck CP. The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial. Nicotine Tob Res 2008; 10:213 - 8; http://dx.doi.org/10.1080/14622200701704921; PMID: 18188762
   PubMed Web of Science ®Google Scholar
• Cytos Biotechnology. CYT002 Nic Qb: a novel vaccine for nicotine addiction. Zurich: Cytos Biotechnology; 2012. [http://www.cytos.com/userfiles/file/Cytos_Press_E_091015.pdf (accessed on January 15, 2012)]
   Google Scholar
• Roiko SA, Harris AC, Keyler DE, Lesage MG, Zhang Y, Pentel PR. Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats. J Pharmacol Exp Ther 2008; 325:985 - 93; http://dx.doi.org/10.1124/jpet.107.135111; PMID: 18305013
   PubMed Web of Science ®Google Scholar
• Raupach T, van Schayck CP. Pharmacotherapy for smoking cessation: current advances and research topics. CNS Drugs 2011; 25:371 - 82; http://dx.doi.org/10.2165/11590620-000000000-00000; PMID: 21476609
   PubMed Web of Science ®Google Scholar
• Leader AE, Lerman C, Cappella JN. Nicotine vaccines: will smokers take a shot at quitting?. Nicotine Tob Res 2010; 12:390 - 7; http://dx.doi.org/10.1093/ntr/ntq015; PMID: 20185516
   PubMed Web of Science ®Google Scholar
• Carrozzi L, Pistelli F, Viegi G. Pharmacotherapy for smoking cessation. Ther Adv Respir Dis 2008; 2:301 - 17; http://dx.doi.org/10.1177/1753465808096136; PMID: 19124379
   PubMedGoogle Scholar
• Hall WD. Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?. PLoS Med 2005; 2:e266 - , quiz e351; http://dx.doi.org/10.1371/journal.pmed.0020266; PMID: 16173831
   PubMed Web of Science ®Google Scholar
• Maurer P, Jennings GT, Willers J, Rohner F, Lindman Y, Roubicek K, et al. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity. Eur J Immunol 2005; 35:2031 - 40; http://dx.doi.org/10.1002/eji.200526285; PMID: 15971275
   PubMed Web of Science ®Google Scholar
• Cornuz J, Zwahlen S, Jungi WF, Osterwalder J, Klingler K, van Melle G, et al. A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One 2008; 3:e2547; http://dx.doi.org/10.1371/journal.pone.0002547; PMID: 18575629
   PubMed Web of Science ®Google Scholar
• Successful Results from Second Clinical Trial of Anti-Smoking Vaccine, TA-NIC; 2004 [http://www.globenewswire.com/newsroom/news.html?d=60776 (accessed on January 15, 2012)]
   Google Scholar
• Xenova Group plc: Anti-Smoking Vaccine TA-NIC Preliminary 12 Month Clinical Trial Results [press release]. Berkshire, UK: Xenowa Group; 2005 [http://www.globenewswire.com/newsroom/news.html?d=73733 (accessed on January 15, 2012)]
   Google Scholar
• ClinicalTrials.gov [http://www.clinicaltrials.gov/ct2/show/NCT00633321?term=TA-NIC&rank=1 (accessed on January 14, 2012)]
   Google Scholar
• Nabi Biopharmaceuticals: Clinical Trials. NicVAX® (Nicotine Conjugate Vaccine) [http://www.nabi.com/pipeline/clinicaltrials.php (accessed on November 11, 2012)]
   Google Scholar
• Hatsukami DK, Rennard S, Jorenby D, Fiore M, Koopmeiners J, de Vos A, et al. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Clin Pharmacol Ther 2005; 78:456 - 67; http://dx.doi.org/10.1016/j.clpt.2005.08.007; PMID: 16321612
   PubMed Web of Science ®Google Scholar
• Nabi Biopharmaceuticals: News Release. Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial [http://phx.corporate-ir.net/phoenix.zhtml?c=100445&p=irol-newsArticle&ID=1626882&highlight (accessed on January 14, 2012)]
   Google Scholar
• The Local. Sweden’s News in English. Swedish anti-smoking vaccine to undergo tests [http://www.thelocal.se/11392/20080428/ (accessed on March 15, 2012)]
   Google Scholar
• Oliver JL, Pashmi G, Barnett P, Mettens P, Biemans R, Monteyne P, et al. Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies. Vaccine 2007; 25:7354 - 62; http://dx.doi.org/10.1016/j.vaccine.2007.08.019; PMID: 17870213
   PubMed Web of Science ®Google Scholar
• Bevins RA, Wilkinson JL, Sanderson SD. Vaccines to combat smoking. Expert Opin Biol Ther 2008; 8:379 - 83; http://dx.doi.org/10.1517/14712598.8.4.379; PMID: 18352843
   PubMed Web of Science ®Google Scholar
• Le Houezec J. Why a nicotine vaccine?. Clin Pharmacol Ther 2005; 78:453 - 5; http://dx.doi.org/10.1016/j.clpt.2005.08.008; PMID: 16321611
   PubMed Web of Science ®Google Scholar
• Fahim RE, Kessler PD, Fuller SA, Kalnik MW. Nicotine vaccines. CNS Neurol Disord Drug Targets 2011; 10:905 - 15; PMID: 22229310
   PubMed Web of Science ®Google Scholar
• Keyler DE, Shoeman D, LeSage MG, Calvin AD, Pentel PR. Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats. J Pharmacol Exp Ther 2003; 305:587 - 92; http://dx.doi.org/10.1124/jpet.102.046805; PMID: 12606612
   PubMed Web of Science ®Google Scholar
• Kuehn BM. Could a novel vaccine help smokers quit?. JAMA 2005; 294:891 - 2; http://dx.doi.org/10.1001/jama.294.8.891; PMID: 16118374
   PubMed Web of Science ®Google Scholar
• LeSage MG, Keyler DE, Pentel PR. Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies. AAPS J 2006; 8:E65 - 75; http://dx.doi.org/10.1208/aapsj080108; PMID: 16584135
   PubMed Web of Science ®Google Scholar
• Gartner CE, Barendregt JJ, Wallace A, Hall WD. Would vaccination against nicotine be a cost-effective way to prevent smoking uptake in adolescents?. Addiction 2012; 107:801 - 9; http://dx.doi.org/10.1111/j.1360-0443.2011.03718.x; PMID: 22084967
   PubMed Web of Science ®Google Scholar